FM
fazen.markets
equities·esfritzh

Citadel Slashes SpaceX 94%, Amazon 56% in $900B Q3 Reshuffle

0h ago|5 min readStandard
FM

Fazen Markets

Source: benzinga.com

Written by AI from a primary source ·

citadel-13fken-griffin-portfolio13f-filingshedge-fund-positioningmarvell-technology
Sponsoredby Fazen Capital

AiX — Free Expert Advisor

Trades XAUUSD on autopilot. Verified Myfxbook performance. Free forever.

Myfxbook verified No subscription XAUUSD M15
Get Free EA

Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. AiX is informational software — not investment advice. Past performance does not guarantee future results.

Key Takeaways

  • 1Citadel's Q3 13F lands against a soft tape.
  • 2The headline figure is the 729% raise in Marvell, dwarfing every other addition in the book.
  • 3The cuts to AbbVie and Abbott, both at roughly 80%, remove two large healthcare anchors from the book at once.

Partner

Trade 800+ Global Stocks & ETFs

Regulated Broker Competitive Spreads

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Ken Griffin's Citadel reshaped its $900 billion portfolio in the third quarter, cutting Space Exploration Technologies Corp. (NASDAQ:SPCX) by 94% and Amazon.com Inc. (NASDAQ:AMZN) by 56%, while raising Marvell Technology Inc. (NASDAQ:MRVL) by 729%, according to its latest 13F filing. The firm added 2,490 positions and fully exited 2,219 across 13,843 holdings. As of 11:01 UTC today, SPCX traded at $137.36, down 1.84%, AMZN at $257.75, down 3.62%, and AMD at $504.28, down 13.84%.

Context — Why Citadel's Q3 Filing Matters Now

Citadel's Q3 13F lands against a soft tape. The S&P 500 fell nearly 1% in October, and Goldman Sachs prime brokerage data flagged Oct. 22 as one of the worst days for hedge funds since COVID-19. Griffin's $77 billion flagship fund still gained 1.7% that month, lifting its year-to-date return to 15.3%, the best among multistrategy peers. The filing's scale — 13,843 holdings and more than 2,000 exits — reflects a book built for that kind of tape.

The largest cuts cluster in mega-cap technology and healthcare. Beyond SPCX and AMZN, Citadel reduced Advanced Micro Devices Inc. (NASDAQ:AMD) by 61% and Apple Inc. (NASDAQ:AAPL) by 37%. In healthcare, AbbVie Inc. (NYSE:ABBV) fell 81% and Abbott Laboratories (NYSE:ABT) fell 80%. Energy exposure narrowed too, with Chevron Corporation (NYSE:CVX) down 76%.

The single biggest raise, by a wide margin, is Marvell at 729%. Citadel also lifted Procter & Gamble Company (NYSE:PG) by 189% and Mastercard Incorporated (NYSE:MA) by 161%. New stakes include ARK Innovation ETF (NYSE:ARKK), Rocket Lab Corporation (NASDAQ:RKLB) and FTAI Aviation Ltd. (NASDAQ:FTAI).

A separate event sits behind the filing's shape. Leopold Aschenbrenner's AI hedge fund, Situational Awareness, imploded in July after leveraged bets on AI and memory chips went bad. Losses forced it to sell much of its public equity book to Citadel. The fund's assets fell from a $45 billion peak to about $10 billion, mostly private stakes.

Griffin wrote to investors on Aug. 21 that Citadel had shed more than 80% of the aggregate risk from the original portfolio. That liquidation barely registers in the 13F because the filing lists holdings as of Sept. 30, not trades. Citadel acquired the positions in July, after the June 30 cutoff for Q2 filings, and had shed most of that risk by late August.

Data — What the Numbers Show

The headline figure is the 729% raise in Marvell, dwarfing every other addition in the book. Procter & Gamble's 189% increase and Mastercard's 161% increase are the next-largest raises, but both sit far below Marvell's scale. On the exit side, the 94% cut to SPCX is the deepest reduction disclosed, followed by AbbVie at 81%, Abbott at 80%, and Chevron at 76%.

PositionChange
Marvell (MRVL)+729%
Procter & Gamble (PG)+189%
Mastercard (MA)+161%
Apple (AAPL)-37%
Amazon (AMZN)-56%
AMD-61%
Chevron (CVX)-76%
Abbott (ABT)-80%
AbbVie (ABBV)-81%
SpaceX (SPCX)-94%

The top 10 holdings point to a tightly hedged book. Citadel holds both puts and calls on the SPDR S&P 500 ETF Trust (NYSE:SPY), Invesco QQQ Trust (NASDAQ:QQQ) and Micron Technology Inc. (NASDAQ:MU). It also holds calls on Meta Platforms Inc. (NASDAQ:META), NVIDIA Corporation (NASDAQ:NVDA), AMD and Apple. That structure — long options on single names alongside paired puts and calls on broad index ETFs — is what a market-neutral book looks like when conviction sits in volatility rather than direction.

Live quotes add texture. AMD trades at $504.28, down 13.84% today, with a session range of $501.30 to $526.20. Apple sits at $352.78, down 0.59%, inside a $351.31 to $357.10 range. Amazon at $257.75 is down 3.62% on the day.

Analysis — What It Means for Markets and Sectors

The cuts to AbbVie and Abbott, both at roughly 80%, remove two large healthcare anchors from the book at once. Combined with the 76% reduction in Chevron, the pattern reads as a broad retreat from defensives and energy, not a single-sector call. The raises in Procter & Gamble and Mastercard sit on the consumer side, which cuts against a pure risk-off interpretation.

The Marvell increase is the harder signal to read. A 729% raise is large in percentage terms, but the filing does not disclose the resulting dollar value of the position, so the absolute size relative to the $900 billion book is unknown. Marvell sits in the same semiconductor complex as AMD, which Citadel cut by 61%. Holding a large raise in one chip name while cutting another is consistent with relative-value positioning rather than a sector bet.

The new ARKK stake is notable because ARK Innovation is an actively managed thematic ETF, not a single name. Buying the ETF alongside a 729% raise in Marvell and new positions in Rocket Lab and FTAI Aviation points to a basket of high-beta growth and aerospace exposure rather than a concentrated wager.

The Situational Awareness unwind complicates any read of the filing. Citadel absorbed a public equity book in July and shed more than 80% of the aggregate risk by Aug. 21, per Griffin's letter. Whatever remained on Sept. 30 folds into existing positions rather than appearing as a distinct block. That means some of the Q3 position changes may reflect the wind-down of an acquired book rather than fresh conviction. The filing does not break out which positions came from that transaction.

Aschenbrenner's own Q3 13F shows he has since rebuilt a $1.58 billion book in many of the same AI names. That is a reminder that the underlying thesis did not disappear with the fund's use — the structure did.

Outlook — What to Watch Next

The next 13F, due in mid-February for the December quarter, will show whether the Marvell position was held or trimmed. It will also reveal whether the ARKK, Rocket Lab and FTAI Aviation stakes were starter positions or full allocations. Neither the filing nor the report gives a dollar figure for any of these, so the Q4 filing is the first clean read on size.

For the hedged book, the paired SPY and QQQ puts and calls are the tell. If Citadel keeps both legs into year-end, the fund is pricing continued volatility in the index rather than a directional view. If one leg drops out, the posture has changed. The filing will not explain why, but the change itself is observable.

Marvell's price action relative to AMD's will matter. AMD's 13.84% drop today against Marvell's undisclosed move is the kind of dispersion a relative-value book is built to trade. Any continuation of that spread keeps the strategy in play.

Frequently Asked Questions

What does Citadel's 13F actually tell you?

A 13F lists what a fund holds on the last day of a quarter. It is not a trade log, so it shows the snapshot on Sept. 30, not the path taken to get there. Citadel's filing covers 13,843 holdings with 2,490 additions and 2,219 full exits. Because positions acquired in July appear only if still held on Sept. 30, the Situational Awareness book does not show up as a separate block.

Why did Citadel cut SpaceX by 94%?

The filing does not give a reason, and the report does not either. What is disclosed is the size of the reduction: a 94% cut, the deepest of any position in the book. SpaceX traded at $137.36 as of 11:01 UTC today, down 1.84%. A reduction of that size leaves a residual stake, so the position was trimmed rather than closed outright.

Sponsored — AiX

Trade XAUUSD on autopilot — free Expert Advisor

AiX is our free MetaTrader 5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. XAUUSD breakout engine.

Get Free EA

PartnerTrade 800+ global stocks & ETFs

Start Trading
Share

Stay informed

Get market analysis delivered to your inbox.

Join 18,500+ investors

Sponsored

Ready to trade the markets?

Open a demo account in 30 seconds. No deposit required.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Related